Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension
about
Functional polymorphism in human CYP4F2 decreases 20-HETE productionArachidonic acid monooxygenase: Genetic and biochemical approaches to physiological/pathophysiological relevanceCytochrome P450 eicosanoids in hypertension and renal diseaseThe role of epoxyeicosatrienoic acids in the cardiovascular systemAssociation of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese populationAssociation of a CYP4A11 variant and blood pressure in black men20-HETE and blood pressure regulation: clinical implicationsCYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activitiesEvaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular diseaseIncreased blood pressure in mice lacking cytochrome P450 2J5Association between the CYP4A11 T8590C variant and essential hypertension: new data from Han Chinese and a meta-analysisJoint analysis of multiple blood pressure phenotypes in GAW19 data by using a multivariate rare-variant association test.Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes.The correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receiptsEpoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans.The role of 20-HETE in androgen-mediated hypertension.Kinetic analysis of lauric acid hydroxylation by human cytochrome P450 4A11Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel.20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (Gq) to Affect Vascular Function and Trigger Hypertension.Regulation of human cytochrome P450 4F2 expression by sterol regulatory element-binding protein and lovastatin.Sodium reabsorption in the thick ascending limb in relation to blood pressure: a clinical perspective.Cerebrospinal fluid 20-HETE is associated with delayed cerebral ischemia and poor outcomes after aneurysmal subarachnoid hemorrhage.Urinary CYP eicosanoid excretion correlates with glomerular filtration in African-Americans with chronic kidney disease.Cytochrome 4A11 Genetic Polymorphisms Increase Susceptibility to Ischemic Stroke and Associate with Atherothrombotic Events After Stroke in ChineseCYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flowRole of 20-HETE in the antihypertensive effect of transfer of chromosome 5 from Brown Norway to Dahl salt-sensitive rats.CYP4A11 variant is associated with high-density lipoprotein cholesterol in women.Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion InjuryCYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates.The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension.Association of a functional cytochrome P450 4F2 haplotype with urinary 20-HETE and hypertension.Cytochromes p450: roles in diseasesHuman cytochrome p450 family 4 enzymes: function, genetic variation and regulation.Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury.Androgen-sensitive hypertension associated with soluble guanylate cyclase-α1 deficiency is mediated by 20-HETE.Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies.Intravenous formulation of N-hydroxy-N'-(4-n-butyl-2-methylphenyl)formamidine (HET0016) for inhibition of rat brain 20-hydroxyeicosatetraenoic acid formation
P2860
Q24299206-ACAAF4D8-BE93-425D-A5EF-B5BE9E0E06C1Q27024958-25F7F361-8B18-404E-8A43-DAC3DE7833B1Q28252210-B67CF9A6-5C52-400F-88CA-812E2944C17FQ28256560-C2645C04-CCCF-4ABA-85C2-3190CA449EA1Q28272355-9DC06164-6F3F-45F7-BEC1-5C0687BC52CFQ28274987-16BAEB7B-1997-4A81-920A-AFC59827BDFAQ28288942-7A61D61E-A401-45F2-9002-A72D6F133019Q28290987-E2583053-76EA-4EA0-8283-0620606D344DQ28384901-85370D57-EADA-425D-8CA7-84ED2A0956A5Q28509705-BE53C855-6051-4535-B0FA-86663144B3A3Q30000660-5AAA81BD-3B14-4E07-80C0-7DBAE9D9A93EQ31149275-8458DFF4-A910-441E-8C28-820B6D7CE60BQ33671358-946F00D8-730E-4474-8609-69A4760F43B0Q33793971-64FEC1EE-078A-4A41-904F-6FAC47070DD1Q33904690-46FDD7B4-D269-466D-AF15-87A1490FB366Q33970421-1511C6A1-573C-467E-BFE5-1F64CAFB9AB7Q34196923-AAA66D0F-49D8-4B85-B155-8EB27D3EFA59Q34300295-82EC2056-445F-4E18-A4E5-EFF9C51FCF06Q34342711-118838C0-BBFC-4CC3-A2D4-10DC7D58F396Q34378817-526AD576-A599-4E09-B64C-6FAA515AC3D9Q34524859-CD09626A-5F72-4A48-88DE-B477F925BB12Q34553783-4479D207-E7BD-480C-B47D-437A49FA6072Q34586649-151A29E4-E661-4589-BD84-D7C10DE66BA4Q35094692-E2BE631D-1509-4533-A991-0F5BCDF23A7BQ35100896-E8B63D75-8D17-4A62-B597-AD0675D9B5FDQ35404485-15D27222-3A23-482A-9FEC-AA4E2A118124Q35609439-A95D883E-210A-4FB2-ABA3-146A27B4751FQ35842636-CE3147DC-5C69-4342-8C07-BC55F637693DQ35994428-5EFC2A69-4AE5-41AD-A333-E2F38F1F80F2Q36049377-8B217921-136D-4E4B-86B6-30D50DF55824Q36104856-12500FE7-6A35-4B8F-997B-CD3ACB765B5EQ36473507-C037BD42-A84C-409F-A1FD-E01BBBF102F5Q36628304-4618F648-9F81-4100-8F0F-0CA27FB4421AQ36666897-D9674988-E08D-4C61-A689-22E3F99FE628Q36928922-C1D892DF-C1A7-41D9-97CE-1DBCDB891C77Q36929610-8D4595B2-CC8D-4886-BD14-7237D8BD8FFDQ37018428-B11BC7D6-8905-426C-84D5-C9B871150DFAQ37071952-F0420343-68EA-465B-88BE-6B91CE7E51C1Q37109910-CF220708-8B84-44FF-9978-DBE3BB753340Q37138134-05FA6C7D-F27D-4BDC-A814-0B31E9B33770
P2860
Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Functional variant of CYP4A11 ...... ed with essential hypertension
@ast
Functional variant of CYP4A11 ...... ed with essential hypertension
@en
Functional variant of CYP4A11 ...... ed with essential hypertension
@nl
type
label
Functional variant of CYP4A11 ...... ed with essential hypertension
@ast
Functional variant of CYP4A11 ...... ed with essential hypertension
@en
Functional variant of CYP4A11 ...... ed with essential hypertension
@nl
prefLabel
Functional variant of CYP4A11 ...... ed with essential hypertension
@ast
Functional variant of CYP4A11 ...... ed with essential hypertension
@en
Functional variant of CYP4A11 ...... ed with essential hypertension
@nl
P2093
P1433
P1476
Functional variant of CYP4A11 ...... ed with essential hypertension
@en
P2093
Aouatef Bellamine
Chao-Yu Guo
Christopher J O'Donnell
Elliott P Dawson
James V Gainer
Jorge H Capdevila
Kristie E Womble
Michael R Waterman
Nancy J Brown
Sarah W Grant
P356
10.1161/01.CIR.0000151309.82473.59
P407
P577
2004-12-20T00:00:00Z